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     Muscarinic acetylcholine receptors (mAChRs) represent an excellent model system 
to study orthosteric and allosteric interactions. The high sequence homology shown by 
orthosteric sites of mAChRs has hampered the development of subtype selective 
agonists. On the other hand, allosteric recognition sites are less conserved among the 
various mAChR subtypes. 
We synthesized a series of hybrid ligands designed to simultaneously interact with 
both orthosteric and allosteric sites (“dualsteric” compounds) by fusing orthosteric 
activators with M2-selective allosteric fragments (W84 and Naphmethonium). In 
particular, among the oxotremorine-like orthosteric agents, iperoxo emerged as a potent 
agonist with supraphysiological efficacy but devoid of subtype selectivity.
1
 To explore 
the whole chemical space of the binding region, we modified the structure of the three 
component parts (orthosteric and allosteric moieties and spacer) of dualsteric ligands.
2
 
These ligands permitted to prove for the first time that GPCR’s allosteric vestibule is 
able to control the extent of receptor movement to govern a hierarchical order of G-
protein coupling.
3
 In addition, they were found to dynamically switch between two 
distinct binding orientations, engendering both active and inactive populations of 
receptors bound by a given ligand.
4
 More recently, some of these ligands (notably N-8-
IPER) revealed interesting antinociceptive properties and good tolerability.
5
 The 
synthetic approaches together with relevant results and implications of the biological 
investigation will be presented. 
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